Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-01

FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZYBIC (meloxicam) filed by Redmont Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYBIC (Meloxicam)

Snippet

SUPPL AP for ZYBIC (MELOXICAM)